Explore the key areas of your health we measure and monitor.
Hormones, Thyroid & Reproductive HealthMetabolic and cardiovascular healthInflammation and ImmunitiesOrgan Function and detoxificationLifestyle, general and well-being
A focused look at hormone balance, thyroid function, and reproductive health markers that influence energy, mood, metabolism, and long-term wellbeing.
Add-on
Luteinizing hormone from pituitary stimulating ovulation in women and testosterone production in men.
Add-on
Active thyroid hormone affecting metabolism. Used in detailed thyroid evaluation.
1/year
Primary estrogen regulating reproductive and bone health. Levels vary by sex, age, and cycle phase.
1/year
Morning cortisol reflecting HPA axis activity. Abnormal levels indicate adrenal dysfunction or stress adaptation issues.
1/year
Unbound thyroxine hormone. Low levels suggest hypothyroidism, high indicate hyperthyroidism.
Add-on
Follicle-stimulating hormone driving follicle development and spermatogenesis. Abnormal levels indicate gonadal dysfunction.
1/year
Adrenal steroid precursor reflecting adrenal androgen production. Altered levels occur in adrenal or gonadal disorders.
Gain a deeper understanding of your heart and metabolic health through biomarkers that assess cholesterol, blood sugar regulation, cardiovascular risk, and overall metabolic performance.
2/year
Average hemoglobin amount per red blood cell. Useful for classifying anemias.
2/year
A laboratory measurement. Consult clinical resources for specific interpretation.
1/year
A subclass of low-density lipoprotein (LDL) particles of intermediate size, associated with cardiovascular risk assessment.
2/year
The proportion of blood volume occupied by red blood cells. Low values indicate anemia. High values suggest dehydration or polycythemia.
2/year
Average glycemia over prior 8–12 weeks. Used to diagnose and monitor diabetes management.
1/year
Serum iron measures circulating iron bound to transferrin. Low in iron deficiency, high in overload.
2/year
Serum glucose is the level of sugar in the blood and serves as the body’s primary source of energy.
2/year
An algorithmic estimate of physiological age derived from biomarker patterns and clinical data. Used to track aging-related changes relative to chronological age.
1/year
Determines blood type (A, B, AB, O) based on surface antigens.
Essential for transfusions and transplant compatibility.
Add-on
A genetically determined lipoprotein particle similar to LDL that is associated with increased cardiovascular risk.
1/year
May predict cardiovascular risk better than LDL-C by reflecting particle burden.
1/year
A measurement of the concentration of small, dense LDL particles in the blood.
1/year
A blood test that measures the body’s capacity to bind and transport iron, reflecting transferrin availability.
2/year
Oxygen-carrying protein in red blood cells. Low hemoglobin indicates anemia and reduced oxygen delivery. High levels may reflect dehydration or polycythemia.
1/year
Iron storage protein indicating iron stores. Low ferritin indicates deficiency, high may reflect inflammation or iron overload.
2/year
Structural protein on atherogenic lipoproteins. Reflects particle number and cardiovascular risk.
2/year
HDL-Cholesterol: A laboratory measurement. Consult clinical resources for specific interpretation.
2/year
Average concentration of hemoglobin in red blood cells. Used in anemia evaluation.
2/year
Average platelet size. Higher MPV indicates younger, more reactive platelets often seen with increased turnover.
2/year
Average red blood cell size. Helps classify anemia as microcytic, normocytic, or macrocytic.
1/year
May predict cardiovascular risk better than LDL-C by reflecting particle burden.
1/year
Leptin: A laboratory measurement. Consult clinical resources for specific interpretation.
1/year
A classification of LDL particles based on their size and density, indicating cardiovascular risk.
2/year
Pancreatic hormone regulating glucose uptake. Fasting hyperinsulinemia suggests insulin resistance.
1/year
Iron % saturation: A laboratory measurement. Consult clinical resources for specific interpretation.
1/year
HDL Large refers to the larger, more protective subfraction of high-density lipoprotein (HDL) particles involved in cholesterol transport.
1/year
The arachidonic acid to EPA ratio (AA/EPA) assesses the balance between pro-inflammatory omega-6 and anti-inflammatory omega-3 fatty acids at the cellular level. Lower ratios indicate better inflammatory balance, while elevated ratios suggest increased inflammatory potential and are associated with various chronic diseases.
Assess biomarkers linked to brain function, neurological health, nutrient status, and factors that influence memory, focus, mood, and cognitive performance.
2/year
High-sensitivity C-reactive protein (hs-CRP): A laboratory measurement. Consult clinical resources for specific interpretation.
2/year
Proportion of basophils, involved in allergic reactions and histamine release.
2/year
Proportion of eosinophils, associated with allergic responses and parasitic infections.
2/year
Proportion of lymphocytes among white cells. Changes reflect viral infections, chronic inflammation, or immune disorders.
2/year
A key electrolyte that reflects bicarbonate levels and helps regulate the body’s acid–base (pH) balance.
1/year
A test detecting autoantibodies against nuclear components. Positive ANA suggests autoimmune conditions like SLE but requires clinical correlation.
Monitor the health of your body's vital organs through biomarkers that assess liver and kidney function, detoxification pathways, and overall physiological performance to support long-term wellbeing.
1/year
An enzyme primarily produced by the pancreas that helps break down dietary fats and is measured in blood to assess pancreatic function.
2/year
A urine test that detects ketones, indicating fat breakdown for energy instead of glucose.
1/year
Gamma‑glutamyl transferase, sensitive to biliary injury and alcohol exposure. Elevated in cholestasis.
1/year
Essential cofactor for many enzymes and neuromuscular function. Low magnesium can cause arrhythmias and muscle cramps.
2/year
Carbon dioxide (bicarbonate, CO₂): A laboratory measurement. Consult clinical resources for specific interpretation.
2/year
A liver enzyme that helps convert proteins into energy and is a key marker of liver health.
1/year
A urine test that measures small amounts of albumin to detect early kidney damage.
2/year
Primary plasma protein synthesized by the liver. Maintains oncotic pressure and transports small molecules. Low levels suggest liver disease or malnutrition.
2/year
The presence of white blood cells (leukocytes) in urine, typically used as an indicator of infection or inflammation in the urinary tract.
2/year
Mineral crucial for bone health, neuromuscular function, and signaling. Abnormal levels suggest parathyroid, renal, or vitamin D disorders.
2/year
Aspartate aminotransferase (AST): A laboratory measurement. Consult clinical resources for specific interpretation.
2/year
A urine marker that detects bilirubin, a byproduct of red blood cell breakdown, used to assess liver and bile duct health.
1/year
An enzyme that helps digest carbohydrates and is commonly used to assess pancreatic health.
2/year
Enzyme from liver and bone. Elevated in cholestasis, bone turnover, or biliary obstruction.
2/year
Urea concentration reflecting protein metabolism and renal excretion. Elevated in renal impairment or volume depletion.
2/year
A muscle metabolism byproduct cleared by kidneys. Elevated serum creatinine suggests reduced glomerular filtration.
2/year
Primary circulating sugar. Fasting elevation signals insulin resistance, prediabetes, or diabetes.
2/year
Globulin: A laboratory measurement. Consult clinical resources for specific interpretation.
2/year
Major extracellular anion assisting acid‑base balance. Deviations occur with metabolic disturbances and renal dysfunction.
2/year
Estimated glomerular filtration rate assessing kidney filtration capacity. Lower values indicate impaired renal function.
2/year
Mineral crucial for bone health, neuromuscular function, and signaling. Abnormal levels suggest parathyroid, renal, or vitamin D disorders.
2/year
Major extracellular anion assisting acid‑base balance. Deviations occur with metabolic disturbances and renal dysfunction.
2/year
Urine color is a visual indicator of hydration status and possible underlying health conditions.
2/year
A visual assessment of urine clarity and color used to provide initial insights into hydration and possible health conditions.
1/year
A blood test ratio that compares albumin and globulin levels to assess liver function, immune status, and overall protein balance.
Understand the biomarkers that reflect your overall health, nutritional status, and lifestyle habits, helping you build a stronger foundation for energy, resilience, healthy ageing, and everyday performance.
Add-on
Amino acid linked to B‑vitamin metabolism. Elevated levels associate with vascular risk and methylation defects.
Add-on
A metabolic byproduct measured in blood or urine that helps assess vitamin B12 status.
1/year
Essential cofactor for many enzymes and neuromuscular function. Low magnesium can cause arrhythmias and muscle cramps.
Add-on
Luteinizing hormone from pituitary stimulating ovulation in women and testosterone production in men.
Add-on
Active thyroid hormone affecting metabolism. Used in detailed thyroid evaluation.
1/year
Primary estrogen regulating reproductive and bone health. Levels vary by sex, age, and cycle phase.
1/year
Morning cortisol reflecting HPA axis activity. Abnormal levels indicate adrenal dysfunction or stress adaptation issues.
1/year
Unbound thyroxine hormone. Low levels suggest hypothyroidism, high indicate hyperthyroidism.
Add-on
Follicle-stimulating hormone driving follicle development and spermatogenesis. Abnormal levels indicate gonadal dysfunction.
1/year
Adrenal steroid precursor reflecting adrenal androgen production. Altered levels occur in adrenal or gonadal disorders.
2/year
Average hemoglobin amount per red blood cell. Useful for classifying anemias.
2/year
A laboratory measurement. Consult clinical resources for specific interpretation.
1/year
A subclass of low-density lipoprotein (LDL) particles of intermediate size, associated with cardiovascular risk assessment.
2/year
The proportion of blood volume occupied by red blood cells. Low values indicate anemia. High values suggest dehydration or polycythemia.
2/year
Average glycemia over prior 8–12 weeks. Used to diagnose and monitor diabetes management.
1/year
Serum iron measures circulating iron bound to transferrin. Low in iron deficiency, high in overload.
2/year
Serum glucose is the level of sugar in the blood and serves as the body’s primary source of energy.
2/year
An algorithmic estimate of physiological age derived from biomarker patterns and clinical data. Used to track aging-related changes relative to chronological age.
1/year
Determines blood type (A, B, AB, O) based on surface antigens.
Essential for transfusions and transplant compatibility.
Add-on
A genetically determined lipoprotein particle similar to LDL that is associated with increased cardiovascular risk.
1/year
May predict cardiovascular risk better than LDL-C by reflecting particle burden.
1/year
A measurement of the concentration of small, dense LDL particles in the blood.
1/year
A blood test that measures the body’s capacity to bind and transport iron, reflecting transferrin availability.
2/year
Oxygen-carrying protein in red blood cells. Low hemoglobin indicates anemia and reduced oxygen delivery. High levels may reflect dehydration or polycythemia.
1/year
Iron storage protein indicating iron stores. Low ferritin indicates deficiency, high may reflect inflammation or iron overload.
2/year
Structural protein on atherogenic lipoproteins. Reflects particle number and cardiovascular risk.
2/year
HDL-Cholesterol: A laboratory measurement. Consult clinical resources for specific interpretation.
2/year
Average concentration of hemoglobin in red blood cells. Used in anemia evaluation.
2/year
Average platelet size. Higher MPV indicates younger, more reactive platelets often seen with increased turnover.
2/year
Average red blood cell size. Helps classify anemia as microcytic, normocytic, or macrocytic.
1/year
May predict cardiovascular risk better than LDL-C by reflecting particle burden.
1/year
Leptin: A laboratory measurement. Consult clinical resources for specific interpretation.
1/year
A classification of LDL particles based on their size and density, indicating cardiovascular risk.
2/year
Pancreatic hormone regulating glucose uptake. Fasting hyperinsulinemia suggests insulin resistance.
1/year
Iron % saturation: A laboratory measurement. Consult clinical resources for specific interpretation.
1/year
HDL Large refers to the larger, more protective subfraction of high-density lipoprotein (HDL) particles involved in cholesterol transport.
1/year
The arachidonic acid to EPA ratio (AA/EPA) assesses the balance between pro-inflammatory omega-6 and anti-inflammatory omega-3 fatty acids at the cellular level. Lower ratios indicate better inflammatory balance, while elevated ratios suggest increased inflammatory potential and are associated with various chronic diseases.
2/year
High-sensitivity C-reactive protein (hs-CRP): A laboratory measurement. Consult clinical resources for specific interpretation.
2/year
Proportion of basophils, involved in allergic reactions and histamine release.
2/year
Proportion of eosinophils, associated with allergic responses and parasitic infections.
2/year
Proportion of lymphocytes among white cells. Changes reflect viral infections, chronic inflammation, or immune disorders.
2/year
A key electrolyte that reflects bicarbonate levels and helps regulate the body’s acid–base (pH) balance.
1/year
A test detecting autoantibodies against nuclear components. Positive ANA suggests autoimmune conditions like SLE but requires clinical correlation.
1/year
An enzyme primarily produced by the pancreas that helps break down dietary fats and is measured in blood to assess pancreatic function.
2/year
A urine test that detects ketones, indicating fat breakdown for energy instead of glucose.
1/year
Gamma‑glutamyl transferase, sensitive to biliary injury and alcohol exposure. Elevated in cholestasis.
1/year
Essential cofactor for many enzymes and neuromuscular function. Low magnesium can cause arrhythmias and muscle cramps.
2/year
Carbon dioxide (bicarbonate, CO₂): A laboratory measurement. Consult clinical resources for specific interpretation.
2/year
A liver enzyme that helps convert proteins into energy and is a key marker of liver health.
1/year
A urine test that measures small amounts of albumin to detect early kidney damage.
2/year
Primary plasma protein synthesized by the liver. Maintains oncotic pressure and transports small molecules. Low levels suggest liver disease or malnutrition.
2/year
The presence of white blood cells (leukocytes) in urine, typically used as an indicator of infection or inflammation in the urinary tract.
2/year
Mineral crucial for bone health, neuromuscular function, and signaling. Abnormal levels suggest parathyroid, renal, or vitamin D disorders.
2/year
Aspartate aminotransferase (AST): A laboratory measurement. Consult clinical resources for specific interpretation.
2/year
A urine marker that detects bilirubin, a byproduct of red blood cell breakdown, used to assess liver and bile duct health.
1/year
An enzyme that helps digest carbohydrates and is commonly used to assess pancreatic health.
2/year
Enzyme from liver and bone. Elevated in cholestasis, bone turnover, or biliary obstruction.
2/year
Urea concentration reflecting protein metabolism and renal excretion. Elevated in renal impairment or volume depletion.
2/year
A muscle metabolism byproduct cleared by kidneys. Elevated serum creatinine suggests reduced glomerular filtration.
2/year
Primary circulating sugar. Fasting elevation signals insulin resistance, prediabetes, or diabetes.
2/year
Globulin: A laboratory measurement. Consult clinical resources for specific interpretation.
2/year
Major extracellular anion assisting acid‑base balance. Deviations occur with metabolic disturbances and renal dysfunction.
2/year
Estimated glomerular filtration rate assessing kidney filtration capacity. Lower values indicate impaired renal function.
2/year
Mineral crucial for bone health, neuromuscular function, and signaling. Abnormal levels suggest parathyroid, renal, or vitamin D disorders.
2/year
Major extracellular anion assisting acid‑base balance. Deviations occur with metabolic disturbances and renal dysfunction.
2/year
Urine color is a visual indicator of hydration status and possible underlying health conditions.
2/year
A visual assessment of urine clarity and color used to provide initial insights into hydration and possible health conditions.
1/year
A blood test ratio that compares albumin and globulin levels to assess liver function, immune status, and overall protein balance.
Add-on
Amino acid linked to B‑vitamin metabolism. Elevated levels associate with vascular risk and methylation defects.
Add-on
A metabolic byproduct measured in blood or urine that helps assess vitamin B12 status.
1/year
Essential cofactor for many enzymes and neuromuscular function. Low magnesium can cause arrhythmias and muscle cramps.